Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
More Stories
Firefly Aerospace kicks off first moon mission after SpaceX launch
The lander of Texas-based rocket and spacecraft builder Firefly Aerospace has begun a 45-day trip to the moon.
Disney wins the 2024 box office as year-end receipts offer a welcome boost
Full-year ticket sales were down just 3.4% from 2023, reaching $8.74 billion, a far cry from the nearly 27% shortage...
Goldman Sachs tops estimates on strong trading results
Goldman's fourth-quarter results will give investors a preview of what to expect this year, as investment banking and trading fees...
JPMorgan Chase is set to report fourth-quarter earnings – here’s what the Street expects
JPMorgan's results will be closely watched for signs that industry optimism is warranted.
Boeing delivered 30 airplanes in December, but gap with Airbus widened in 2024
Boeing delivered 348 airplanes in 2024, less than half of rival Airbus's deliveries.
CFPB sues Capital One for ‘cheating’ customers out of over $2 billion in interest
The Consumer Financial Protection Bureau announced it was suing Capital One for "cheating" customers out of more than $2 billion...